Midi Health, a Palo Alto, CA-based women’s telehealth company, has raised $100 million in a Series D funding round led by Goodwater Capital.
The round also saw participation from Foresite Capital and Serena Ventures, as well as continued support from Advance Venture Partners, GV (Google Ventures), Emerson Collective, SemperVirens, McKesson Ventures, and Felicis Ventures.
The company is valued at $1 billion.
Read More:Airrived Raises $6.1M in Seed Funding
The company plans to use the funds to expand its operations and continue developing its products.
Midi Health, the fastest-growing women’s telehealth company, was founded to fix the most significant gaps in women’s care—gaps that affect women, families, and the economy.
Driven by strong patient adoption and results, Midi Health has grown into a scalable platform with nationwide insurance, reaching over 45 million women. Each week, 25,000+ patients get care from experts in OB-GYN, cardiology, endocrinology, dermatology and more. Using AI to support decisions and reduce strain, Midi is expanding quality care for women. With 2 million U.S. women entering menopause each year—and untreated symptoms costing $25 billion annually—closing care gaps across the lifespan could add nearly $295 billion to the economy by 2040.
Midi’s unique AI system creates value in three main areas:
- Personalising care: AI reviews patient charts to customise care, helping doctors diagnose and manage treatment more quickly and accurately.
- Streamlining operations: Automation improves scheduling, triage, and documentation.
- Improving results: Using one of the most extensive women’s health datasets helps research and improves clinical guidelines.
“Goodwater strongly supports Midi Health’s goal to transform women’s healthcare for the long term,” said Eric Kim, co-founder and managing partner at Goodwater Capital. “Midi’s fast growth shows the strength of its care team, patient-focused approach, and AI technology that provides personalised care and supports expansion.”
Midi’s care model delivers clear and measurable results.
Midi combines medical expertise, technology, and data to improve outcomes for women’s health.
- 28% increase in following breast cancer screening guidelines
- 11% increase in following colorectal cancer screening guidelines
- Up to 13% lower total healthcare costs compared to a similar group
Midi has also seen significant improvements in patients’ A1c and LDL levels.
“When women founders and women customers are listened to, real change happens,” said Serena Williams, managing partner at Serena Ventures. “We have followed Joanna and her team for years and are impressed by how much they have grown. They are providing important care that every woman should be able to access, in a healthcare area worth billions of dollars.”
Leadership Update
To support its next stage of growth, the company is adding new leaders to its executive team:
- Chief Financial Officer Jason Wheeler has strong experience growing fast-moving companies and previously held leadership roles at Tesla, Google, and Forward.
- Chief Marketing Officer Melissa Waters has a proven record of driving company growth and previously worked at Meta, Lyft, and Hims & Hers.
- Chief Commercial Officer Matt Cook has spent his career leading health technology companies, including Omada Health and Firefly Health.
About Midi Health
Founded in 2021 and led by CEO Joanna Strober, Midi Health is creating a new approach to healthcare. As one of the fastest-growing women’s telehealth companies in the U.S., Midi offers easy, insurance-covered care in all 50 states, designed by leading medical experts. The company is known for care in perimenopause and menopause and aims to support women’s health needs at every stage of life.
Read More:Synthpop Raises $15M in Series A Funding
